$38.13 0.22 (+0.58%)
2/13/2012 2:37 PM

Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Featured Broker Partners


Advertisement